Success Stories: EB-1A Approval for Postdoctoral Research Associate in North Carolina in the Field of Molecular Immunology

Client’s Testimonial:

 

Dear [WeGreened Team], Thank you very much for the wonderful news and I am really happy, WeGreened Team [North America Immigration Law Group]is the best in every aspect of I-140 success. I never called your team because you always address my questions and problem by mail very quickly with accurate information. I would like to thank [WeGreened Team] for the excellent job (one of the best team).
 


On May 12th, 2014 We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Research Associate in the Field of Molecular Immunology (Approval Notice)


General Field: Molecular Immunology

Position at the Time of Case Filing: Postdoctoral Research Associate

National Origin: India

Service Center: Texas Service Center (TSC)

Residence at the Time of Filing: North Carolina

Approval Notice Date: May 12, 2014

Processing Time: 4 months, 12 days

 


Case Summary:

In this case, the client that we had the pleasure of working with was a Postdoctoral Research Associate from India in the field of molecular immunology.  He had conducted his research in the highly specialized areas of molecular oncology, including expression profiles of mucins, the roles of mucins in pancreatic and gastric cancers, and infectious diseases.  This work had resulted in 11 peer-reviewed scientific articles and 24 presentations at national and international conferences.  At the time that his case was filed, these publications been cited at least 293 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work.  In addition, he had served as a manuscript reviewer and editorial board member for a distinctive, internationally-circulated journal, and had reviewed abstracts for the scientific society Sigma Xi.  The importance of his continued work was confirmed in the following quote from an independent recommender, “As over 90% of people will be exposed to HSV1 at least once in their lifetime, it is critical that [he] is allowed to continue his critical research. His work has already enabled the advancement of protective measures against these viruses and more and it would be detrimental to both our country and the world if he were to stop now.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of molecular immunology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 4 months and 12 days.